Rahul S. Bhansali

956 total citations · 1 hit paper
21 papers, 427 citations indexed

About

Rahul S. Bhansali is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Hematology. According to data from OpenAlex, Rahul S. Bhansali has authored 21 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Public Health, Environmental and Occupational Health, 7 papers in Molecular Biology and 6 papers in Hematology. Recurrent topics in Rahul S. Bhansali's work include Acute Lymphoblastic Leukemia research (8 papers), Acute Myeloid Leukemia Research (3 papers) and Down syndrome and intellectual disability research (3 papers). Rahul S. Bhansali is often cited by papers focused on Acute Lymphoblastic Leukemia research (8 papers), Acute Myeloid Leukemia Research (3 papers) and Down syndrome and intellectual disability research (3 papers). Rahul S. Bhansali collaborates with scholars based in United States, France and Australia. Rahul S. Bhansali's co-authors include Catherine Lai, Keith W. Pratz, Peter S. Klein, Melinda Snitow, John D. Crispino, Shai Izraeli, Paul P. Lee, Amit Agrawal, Nobuko Hijiya and Emily Zhao and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and Oncogene.

In The Last Decade

Rahul S. Bhansali

20 papers receiving 418 citations

Hit Papers

Recent advances in targeted therapies in acute myeloid le... 2023 2026 2024 2025 2023 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rahul S. Bhansali United States 8 171 127 105 66 51 21 427
Giuseppe Germanò Italy 11 141 0.8× 111 0.9× 86 0.8× 39 0.6× 62 1.2× 29 411
Ga Young Lee South Korea 10 120 0.7× 93 0.7× 23 0.2× 52 0.8× 36 0.7× 27 363
Alexander A. Boucher United States 10 77 0.5× 104 0.8× 47 0.4× 30 0.5× 52 1.0× 34 393
Jaswinder Kaur India 11 172 1.0× 57 0.4× 60 0.6× 48 0.7× 220 4.3× 35 564
Албена Тодорова Bulgaria 14 363 2.1× 128 1.0× 28 0.3× 30 0.5× 42 0.8× 71 661
Stephanie Tung Canada 10 120 0.7× 28 0.2× 64 0.6× 68 1.0× 55 1.1× 15 391
Anna Torrent Spain 11 92 0.5× 131 1.0× 72 0.7× 108 1.6× 93 1.8× 40 393
Ching‐Tien Peng Taiwan 11 147 0.9× 57 0.4× 61 0.6× 26 0.4× 94 1.8× 24 479
Wim Renmans Belgium 15 130 0.8× 112 0.9× 36 0.3× 61 0.9× 154 3.0× 26 485
D. Schüler Hungary 11 143 0.8× 87 0.7× 129 1.2× 49 0.7× 42 0.8× 83 426

Countries citing papers authored by Rahul S. Bhansali

Since Specialization
Citations

This map shows the geographic impact of Rahul S. Bhansali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rahul S. Bhansali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rahul S. Bhansali more than expected).

Fields of papers citing papers by Rahul S. Bhansali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rahul S. Bhansali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rahul S. Bhansali. The network helps show where Rahul S. Bhansali may publish in the future.

Co-authorship network of co-authors of Rahul S. Bhansali

This figure shows the co-authorship network connecting the top 25 collaborators of Rahul S. Bhansali. A scholar is included among the top collaborators of Rahul S. Bhansali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rahul S. Bhansali. Rahul S. Bhansali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wertheim, Gerald, Shikha Gaur, Joseph P. Loftus, et al.. (2025). DYRK1A inhibition results in MYC and ERK activation rendering KMT2A-R acute lymphoblastic leukemia cells sensitive to BCL2 inhibition. Leukemia. 39(5). 1078–1089. 1 indexed citations
2.
Rastogi, Supriya, Daniel J. Lewis, Leah Cohen, et al.. (2023). Mogamulizumab Multimodality Therapy with Systemic Retinoids, Interferon, or Extracorporeal Photopheresis for Advanced Cutaneous T‐Cell Lymphoma. Dermatologic Therapy. 2023(1). 2 indexed citations
3.
Bhansali, Rahul S. & Stefan K. Barta. (2023). Central Nervous System Progression/Relapse in Mature T- and NK-Cell Lymphomas. Cancers. 15(3). 925–925. 1 indexed citations
4.
Bhansali, Rahul S. & Stefan K. Barta. (2023). SOHO State of the Art Updates and Next Questions | Challenging Cases in Rare T-Cell Lymphomas. Clinical Lymphoma Myeloma & Leukemia. 23(9). 642–650. 5 indexed citations
5.
Bhansali, Rahul S., Keith W. Pratz, & Catherine Lai. (2023). Recent advances in targeted therapies in acute myeloid leukemia. Journal of Hematology & Oncology. 16(1). 29–29. 137 indexed citations breakdown →
6.
Lai, Catherine, et al.. (2023). Older Adults With Newly Diagnosed AML: Hot Topics for the Practicing Clinician. American Society of Clinical Oncology Educational Book. 43(43). e390018–e390018. 5 indexed citations
7.
Harris, Ethan, et al.. (2022). The chromosome 21 kinase DYRK1A: emerging roles in cancer biology and potential as a therapeutic target. Oncogene. 41(14). 2003–2011. 33 indexed citations
8.
Chen, Wei, Yan Xu, Wentong Guo, et al.. (2021). Caspase-1 inhibition ameliorates murine acute graft versus host disease by modulating the Th1/Th17/Treg balance. International Immunopharmacology. 94. 107503–107503. 5 indexed citations
9.
Snitow, Melinda, Rahul S. Bhansali, & Peter S. Klein. (2021). Lithium and Therapeutic Targeting of GSK-3. Cells. 10(2). 255–255. 74 indexed citations
10.
Chen, Wei, Ying Wang, Kunming Qi, et al.. (2020). Efficacy and Safety of Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Immunoglobulin D Multiple Myeloma. Transplantation and Cellular Therapy. 27(3). 273.e1–273.e5. 6 indexed citations
11.
Hurtz, Christian, Martin Carroll, Sarah K. Tasian, et al.. (2020). DYRK1A Is Required to Alleviate Replication Stress in KMT2A-Rearranged Acute Lymphoblastic Leukemia. Blood. 136(Supplement 1). 39–40. 2 indexed citations
12.
Fruit, Corinne, Rahul S. Bhansali, Mattias F. Lindberg, et al.. (2019). Biological Characterization of 8-Cyclopropyl-2-(pyridin-3-yl)thiazolo[5,4-f]quinazolin-9(8H)-one, a Promising Inhibitor of DYRK1A. Pharmaceuticals. 12(4). 185–185. 7 indexed citations
13.
Bhansali, Rahul S., Sébastien Malinge, Yi-Chien Tsai, et al.. (2018). The Chromosome 21 Kinase DYRK1A and Its Substrate FOXO1 Constitute a Novel Therapeutic Pathway in B-ALL. Blood. 132(Supplement 1). 548–548.
14.
Bhansali, Rahul S., et al.. (2018). STAT3 Is Activated By DYRK1A and Is a Potential Therapeutic Target in B-ALL. Blood. 132(Supplement 1). 3898–3898. 3 indexed citations
16.
Lee, Paul P., Rahul S. Bhansali, Shai Izraeli, Nobuko Hijiya, & John D. Crispino. (2016). The biology, pathogenesis and clinical aspects of acute lymphoblastic leukemia in children with Down syndrome. Leukemia. 30(9). 1816–1823. 41 indexed citations
17.
Thompson, Benjamin J., Rahul S. Bhansali, Lauren Diebold, et al.. (2015). DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3. The Journal of Experimental Medicine. 212(6). 953–970. 50 indexed citations
18.
Bhansali, Rahul S.. (2014). Non-surgical periodontal therapy: An update on current evidence. 3(4). 38–38. 10 indexed citations
19.
Bhansali, Rahul S., et al.. (2012). Smartphone applications for pediatric anesthesia. Pediatric Anesthesia. 22(4). 400–404. 17 indexed citations
20.
Bhansali, Rahul S., et al.. (2008). Periodontal Management of Gingival Enlargement Associated With Sturge‐Weber Syndrome. Journal of Periodontology. 79(3). 549–555. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026